Genome analysis has shown that approximately in 50% of VEXAS-associated MDS, UBA1 mutation is accompanied by isolated variants in genes related to clonal hematopoiesis (CH), most frequently DNMT3A and TET2. This evidence concerns the gene UBA1 and VEXAS syndrome.